# Landos Biopharma, Inc.

Landos Biopharma, Inc. is a company headquartered in Blacksburg, VA, United States.

## Company overview

- **Legal name:** Landos Biopharma, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Blacksburg, VA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001785345

## About

Landos Biopharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001785345, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-21, it reported net income of USD -21,935,000; total assets of USD 38,040,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Net income:** -$21.9M (USD -21,935,000)
- **Total assets:** $38.0M (USD 38,040,000)
- **Cash and equivalents:** $37.5M (USD 37,499,000)
- **Operating cash flow:** -$20.5M (USD -20,477,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$39.3M (USD -39,276,000)
- **Total assets:** $45.3M (USD 45,253,000)
- **Cash and equivalents:** $36.6M (USD 36,640,000)
- **Operating cash flow:** -$45.8M (USD -45,771,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $18.0M (USD 18,000,000)
- **Net income:** -$38.4M (USD -38,422,000)
- **Total assets:** $92.9M (USD 92,879,000)
- **Cash and equivalents:** $8.3M (USD 8,305,000)
- **Operating cash flow:** -$27.1M (USD -27,061,000)

## Recent SEC filings

- Form 8-K — filed 2024-05-23 — period 2024-05-23 — 8-K
- Form 8-K — filed 2024-05-23 — period 2024-05-23 — 8-K
- Form 10-Q — filed 2024-05-09 — period 2024-03-31 — 10-Q
- Form 10-K/A — filed 2024-04-16 — period 2023-12-31 — 10-K/A
- Form 8-K — filed 2024-03-25 — period 2024-03-24 — 8-K
- Form 10-K — filed 2024-03-21 — period 2023-12-31 — 10-K
- Form 8-K — filed 2024-03-21 — period 2024-03-21 — 8-K
- Form 8-K — filed 2024-01-04 — period 2024-01-04 — 8-K
- Form 8-K — filed 2023-11-21 — period 2023-11-21 — 8-K
- Form 10-Q — filed 2023-11-09 — period 2023-09-30 — 10-Q
- Form 8-K — filed 2023-11-09 — period 2023-11-09 — 8-K
- Form 8-K — filed 2023-09-21 — period 2023-09-18 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/landos-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology